Kovai Medical Center & Hospital Ltd carries a clean audit record across seven years, but the record sits alongside a sharp escalation in contingent liabilities and a governance structure where the managing director chairs the committees meant to oversee him. The approximately ₹21.79 crore in GST show-cause notices and the concentration of executive power in three promoter-family members are the two things that shape the risk here.
Key findings
- Contingent liabilities remain elevated, and GST notices demand about ₹21.8 crore
Major- Disputed statutory liabilities not provided for stood at ₹8.15 crore as of 31 March 2025, while unacknowledged claims were ₹54.64 crore as of the same date. On 24 September 2024, the Tamil Nadu GST Department issued four show-cause notices alleging non-collection of taxes on food supplied to inpatient attenders and inpatient medicine sold at MRP, with aggregate demands of approximately ₹21.79 crore. A consumer complaint was allowed against the company on 15 October 2025, directing payment of ₹15,00,000 in compensation and ₹50,000 in litigation expenses. - Audit opinions are unqualified, but CARO reports flag a past cash misappropriation and persistent non-registration of properties
Minor- The statutory auditor issued an unqualified opinion on standalone financial statements every year from FY2020 through FY2026. CARO clause (xi)(a) for FY2022 reported that one cashier misappropriated ₹85 lakhs during the year under audit. The Board's Report for FY2026 disclosed two CARO adverse observations: non-registration of lease agreements with more than 11 months' tenor, and non-registration of immovable property valued at ₹59.31 crore and ₹120.69 crore. - Penalty paid, while show-cause notices from ROC, tax, and safety authorities remain pending
Minor- The Managing Director paid a penalty of ₹25,000 to the Registrar of Companies, Coimbatore during FY2025-26 for a violation under Section 301(1) of the Companies Act, 1956 relating to FY2013-14. The Registrar of Companies issued a show-cause notice on 10 April 2025 for alleged contravention of section 189 of the Companies Act, 2013. The company also received a Show Cause Notice under sections 194 and 206C of the Income Tax Act on 22 August 2024, and a Show Cause Notice from the Directorate of Industrial Safety and Health on 01 August 2024. - Useful-life estimate changes increased depreciation, and Level-3 investments are valued using a cost approach
Clean- In FY2022, management changed the estimated useful life of certain depreciable assets, increasing the depreciation charge by ₹13.19 crore. In FY2020, the company re-assessed the useful life of medical equipment, resulting in a higher depreciation charge of ₹10.92 crore. The company holds investments classified in the Level-3 fair-value hierarchy, valued using a cost approach because cost is considered an estimate of fair value within a wide range of possible fair values and due to restrictions on transferability.
What to watch
- GST show-cause notices. Four show-cause notices issued on 24 September 2024 by the Tamil Nadu GST Department, with aggregate demands of approximately ₹21.79 crore, remain pending as disclosed in the FY2025-26 annual report.
- Stamp duty appeal. The Government of Tamil Nadu's Supreme Court appeal against the Madras High Court ruling on the ₹6.52 crore stamp duty claim, as disclosed in the FY2025-26 annual report.
- Property registration. Resolution of the two immovable property non-registration items, ₹59.31 crore sub judice and ₹120.69 crore pending registration, as reported in the FY2026 Annual Report.
- ROC show-cause notice. Resolution of the notice dated 10 April 2025 for alleged contravention of section 189 of the Companies Act, 2013.
Bottom line: This is a disclosed and consistently audited record with operating cash flow that covers profit and a board that has lost its independent oversight at the committee level. The risk sits in two places: the approximately ₹21.79 crore in GST show-cause notices, which could turn contingent liabilities into real outflows, and a governance structure where the managing director chairs the audit committee that is meant to check him. Watch the GST resolution and whether the board restores independent chairs to its committees.